Fibrin Supports for Flat RPE Monolayer Transplantation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for retinal pigment epithelium (RPE) transplantation face challenges such as low attachment and survival rates, difficulty in maintaining a flat monolayer during transplantation, and potential chronic inflammation due to the use of synthetic polymer substrates that degrade slowly and can cause fibrosis and damage to the underlying choroid.

Innovation Solution

Utilizing fibrin hydrogels as a temporary substrate for RPE transplantation, which can be used as either a basal or apically-apposed support, allowing for controlled degradation and maintaining a flat, wrinkle-free monolayer, and reducing chronic inflammation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If synthetic polymer substrates are used for RPE transplantation, then structural support is provided, but chronic inflammation and fibrosis occur due to slow degradation

Engineering Contradiction:
Improvestructural supportVSAvoidchronic inflammation and fibrosis
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The patent changes the material parameter from synthetic polymer to fibrin, which has different degradation characteristics. Fibrin degrades rapidly through physiological pathways (plasminogen activation) rather than slow synthetic polymer degradation, thereby eliminating chronic inflammation and fibrosis while maintaining necessary structural support during the critical transplantation period.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a temporary, biodegradable fibrin substrate that serves its structural support function during transplantation and then naturally degrades without causing harm. This disposable approach eliminates the need for long-term presence of foreign material, preventing chronic inflammation and fibrosis associated with persistent synthetic polymers.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If RPE single cell suspensions are transplanted, then simplicity of procedure is maintained, but attachment and survival rates are low

Engineering Contradiction:
Improveprocedure simplicityVSAvoidattachment and survival rates
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent introduces a fibrin substrate as an intermediary carrier between the simple cell suspension approach and the need for high attachment rates. The fibrin matrix provides a physiological environment that promotes cell-cell adhesion and survival while maintaining procedural simplicity, acting as a temporary scaffold that facilitates reliable attachment without complex manufacturing.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite structure combining RPE cells with fibrin matrix. This composite approach leverages the adhesive and structural properties of fibrin to enhance cell survival and attachment rates, transforming a simple cell suspension into a cell-matrix construct that maintains ease of administration while dramatically improving reliability.

Inventive Principle:
Principle #40Composite materials

3Stability of the object's composition

If RPE monolayers are grown on unsupported substrates, then cell-cell contact is maintained, but flat wrinkle-free monolayer cannot be maintained during surgery

Engineering Contradiction:
Improvecell-cell contactVSAvoidflat wrinkle-free monolayer
Core Design Contradiction:
Stability of the object's compositionVSShape

Solution Approach 1:

The patent uses a thin fibrin film as a temporary support that maintains the flat, wrinkle-free shape of the RPE monolayer during surgical manipulation. The fibrin film is flexible enough to accommodate surgical handling while providing sufficient structural integrity to prevent wrinkling, and can be easily removed after transplantation without damaging the cell-cell contacts.

Inventive Principle:
Principle #30Flexible shells and thin films

4Duration of action of moving object

If fibrin hydrogel is used as temporary substrate, then controlled degradation is achieved, but precise delivery control during surgery is challenging

Engineering Contradiction:
Improvecontrolled degradationVSAvoiddelivery control
Core Design Contradiction:
Duration of action of moving objectVSEase of operation

Solution Approach 1:

The patent applies antifibrinolytic agents beforehand to prevent premature degradation of the fibrin substrate during surgical handling and implantation. This preliminary protection ensures the fibrin maintains its structural integrity and shape during the critical delivery phase, allowing precise positioning, while still enabling controlled degradation afterward when the therapeutic effect is achieved.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The fibrin hydrogel supports improve RPE attachment and survival, ensuring correct polarity and diffusion permeability, while minimizing inflammation and fibrosis, and can be precisely delivered and controlled during surgical procedures.

Implementation Method 1

controlled degradation

Methodology Applied
Scientific EffectEnzymatic degradation: Enzyme

Implementation Method 2

diffusion permeability

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS20250288724A1Methods and materials for using fibrin supports for retinal pigment epithelium transplantation
Publication Date: 2025.09.18 MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH
  • US20250288724A1 patent drawing
  • US20250288724A1 patent drawing
  • US20250288724A1 patent drawing

AI summary

This document provides methods and materials for performing retinal pigment epithelium transplantation. For example, methods and materials for using fibrin supports for retinal pigment epithelium transplantation are provided.